KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Procter & Gamble (PG) EBT (2016 - 2025)

Procter & Gamble (PG) has disclosed EBT for 17 consecutive years, with $5.4 billion as the latest value for Q4 2025.

  • Quarterly EBT fell 7.25% to $5.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.6 billion through Dec 2025, up 6.12% year-over-year, with the annual reading at $20.2 billion for FY2025, 7.49% up from the prior year.
  • EBT for Q4 2025 was $5.4 billion at Procter & Gamble, down from $6.0 billion in the prior quarter.
  • The five-year high for EBT was $6.0 billion in Q3 2025, with the low at $3.6 billion in Q2 2021.
  • Average EBT over 5 years is $4.7 billion, with a median of $4.6 billion recorded in 2024.
  • Peak annual rise in EBT hit 30.0% in 2024, while the deepest fall reached 11.41% in 2024.
  • Over 5 years, EBT stood at $5.2 billion in 2021, then dropped by 7.71% to $4.8 billion in 2022, then decreased by 7.01% to $4.5 billion in 2023, then soared by 30.0% to $5.8 billion in 2024, then dropped by 7.25% to $5.4 billion in 2025.
  • According to Business Quant data, EBT over the past three periods came in at $5.4 billion, $6.0 billion, and $4.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.